Zusammenfassung
Hauptvertreter der Hypophysen- und Hypothalamushormone sind Gonadotropine, Wachstumshormon und Vasopressinanaloga. Der größte Teil der Verordnungskosten entfällt im Jahr 2003 auf die Gonadotropine, die einen erneuten kräftigen Verordnungszuwachs aufwiesen. Bei den bisher umsatzmäßig führenden Wachstumshormonpräparaten fiel der Anstieg etwas geringer aus.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Collins J (2003): A turbulent area. Fertil Steril 80:1117–1120.
Drake WM, Howell SJ, Monson JP, Shalet SM (2001): Optimizing gh therapy in adults and children. Endocr Rev 22:425–450.
Finkelstein BS, Imperiale TF, Speroff T, Marrero U, Radcliffe DJ, Cuttler L (2002): Effect of growth hormone therapy on height in children with idiopathic short stature: a meta-analysis. Arch Pediatr Adolesc Med 156:230–240.
Frydman R, Howies CM, Truong F (2000): A double-blind, radomized study to compare recombinant human follicle stimulating hormone (FSH; Gonal-F) with highly purified urinary FSH (Metrodin HP) in women undergoing assisted reproductive techniques including intracytoplasmic sperm injection. The French Multicentre Trialists. Hum Reprod 15: 520–525.
International Recombinant Human Chorionic Gonadotropin Study Group (2001): Induction of ovulation in World Health Organization group II anovulatory women undergoing follicular stimulation with recombinant human follicle-stimulating hormone: a comparison of recombinant human chorionic gonadotropin (rhCG) and urinary hCG. Fertil Steril 75:1111–1118.
Takala J, Ruokonen E, Webster NR, Nielsen MS, Zandstra DF, Vundelinckx G, Hinds CJ (1999): Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 341: 785–792.
Van Wely M, Westergaard LG, Bossuyt PMM, van der Ween F (2003a): Effectiveness of human menopausal gonadotropin versus recombinant follicle-stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles: a meta-analysis. Fertil Steril 80:1086–1093.
Van Wely M, Byram N, van der Ween F (2003b): Recombinant FSH in alternative doses or versus urinary gonadotrophins for ouvlation induction in subfertility aossociated with polycystic ovary syndrome: a systematic review based on a Cochrane review. Hum Reprod 18:1143–1149.
Van Wely M, Westergaard LG, Bossuyt PMM, van der Veen F (2004): Human menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cycles. The Cochrane Database Syst Rev 2004(1).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Schwabe, U. (2004). Hypophysen- und Hypothalamushormone. In: Schwabe, U., Paffrath, D. (eds) Arzneiverordnungs-Report 2004. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18513-7_31
Download citation
DOI: https://doi.org/10.1007/978-3-642-18513-7_31
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-21359-8
Online ISBN: 978-3-642-18513-7
eBook Packages: Springer Book Archive